Yahoo Web Search

Search results

    • Should You Buy the Dip on Compass Pathways Stock?

      Should You Buy the Dip on Compass Pathways Stock?

      Motley Fool via Yahoo Finance· 40 minutes ago

      The biotech's lead program, COMP360, is in phase 3 clinical trials right now, and it's being developed to treat treatment-resistant depression (TRD)....